PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist primarily targeting MC3R and MC4R, implicated in modulating sexual arousal and behavior. It has been extensively studied for its potential therapeutic applications in treating hypoactive sexual desire disorder (HSDD) and erectile dysfunction through central nervous system pathways. PT-141’s mechanism involves activation of melanocortin receptors influencing neuroendocrine and autonomic functions. For research purposes only. Not for human consumption.
Any mention of research chemicals, peptides, or related compounds on ProPerformanceMD.com is for educational and informational purposes only. These materials are not intended for human or veterinary use, consumption, or application.
All products and information provided are intended solely for in-vitro laboratory research use only or legitimate scientific investigation.
PT – 141
Login with an approved provider account for pricing.
Description
PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist primarily targeting MC3R and MC4R, implicated in modulating sexual arousal and behavior. It has been extensively studied for its potential therapeutic applications in treating hypoactive sexual desire disorder (HSDD) and erectile dysfunction through central nervous system pathways. PT-141’s mechanism involves activation of melanocortin receptors influencing neuroendocrine and autonomic functions. For research purposes only. Not for human consumption.
Related Products
GLP-2T
Login with an approved provider account for pricing. Read moreKPV
Login with an approved provider account for pricing. Read moreGHK-Cu (Human Copper)
Login with an approved provider account for pricing. Read more